D.B. Root & Company, LLC Vertex Pharmaceuticals Inc Transaction History

D.B. Root & Company, LLC

$296 Million
Q3 2024

A detailed history of D.B. Root & Company, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, D.B. Root & Company, LLC holds 911 shares of VRTX stock, worth $372,380. This represents 0.14% of its overall portfolio holdings.

Number of Shares

911

Previous 1,035 11.98%

Holding current value

$372,380

Previous $485,000 12.78%

% of portfolio

0.14%

Previous 0.17%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$460.0 - $505.78 $57,040 - $62,716	-124 Reduced 11.98%	911 $423,000
Q2 2024 Jul 15, 2024	SELL	$392.81 - $485.53 $141,018 - $174,305	-359 Reduced 25.75%	1,035 $485,000
Q1 2024 Apr 17, 2024	BUY	$407.69 - $446.08 $10,599 - $11,598	26 Added 1.9%	1,394 $582,000
Q4 2023 Jan 16, 2024	SELL	$343.0 - $410.68 $55,566 - $66,530	-162 Reduced 10.59%	1,368 $556,000
Q3 2023 Nov 03, 2023	SELL	$338.18 - $362.46 $4,058 - $4,349	-12 Reduced 0.78%	1,530 $532,000
Q2 2023 Jul 18, 2023	BUY	$314.42 - $351.91 $17,921 - $20,058	57 Added 3.84%	1,542 $542,000
Q1 2023 Apr 18, 2023	BUY	$283.23 - $323.1 $5,664 - $6,462	20 Added 1.37%	1,485 $467,000
Q4 2022 Jan 27, 2023	SELL	$285.76 - $321.48 $8,001 - $9,001	-28 Reduced 1.88%	1,465 $0
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $50,110 - $55,911	183 Added 13.97%	1,493 $432,000
Q2 2022 Jul 21, 2022	SELL	$234.96 - $292.55 $461,461 - $574,568	-1,964 Reduced 59.99%	1,310 $369,000
Q1 2022 May 06, 2022	SELL	$221.42 - $260.97 $131,744 - $155,277	-595 Reduced 15.38%	3,274 $854,000
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $11,328 - $14,300	-64 Reduced 1.63%	3,869 $849,000
Q3 2021 Oct 22, 2021	SELL	$181.39 - $202.99 $139,670 - $156,302	-770 Reduced 16.37%	3,933 $713,000
Q2 2021 Jul 28, 2021	SELL	$187.49 - $221.1 $11,999 - $14,150	-64 Reduced 1.34%	4,703 $948,000
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $486,082 - $566,595	2,348 Added 97.06%	4,767 $1.02 Million
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $500,757 - $667,861	2,419 New	2,419 $571,000
Q1 2020 Apr 29, 2020	SELL	$199.77 - $247.81 $274,683 - $340,738	-1,375 Closed	0 $0
Q4 2019 Jan 14, 2020	SELL	$166.71 - $223.91 $2,500 - $3,358	-15 Reduced 1.08%	1,375 $301,000
Q3 2019 Oct 29, 2019	SELL	$166.23 - $187.09 $129,659 - $145,930	-780 Reduced 35.94%	1,390 $235,000
Q2 2019 Jul 19, 2019	BUY	$164.61 - $190.37 $74,897 - $86,618	455 Added 26.53%	2,170 $397,000
Q1 2019 Apr 12, 2019	BUY	$163.73 - $194.7 $22,103 - $26,284	135 Added 8.54%	1,715 $315,000
Q4 2018 Jan 25, 2019	SELL	$151.91 - $192.21 $28,710 - $36,327	-189 Reduced 10.68%	1,580 $262,000
Q3 2018 Nov 05, 2018	BUY	$167.73 - $192.74 $25,830 - $29,681	154 Added 9.54%	1,769 $341,000
Q2 2018 Jul 25, 2018	BUY	$145.72 - $169.96 $4,371 - $5,098	30 Added 1.89%	1,615 $274,000
Q1 2018 May 02, 2018	BUY	$151.6 - $177.13 $240,286 - $280,751	1,585 New	1,585 $258,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on D.B. Root & Company, LLC with notifications on news.

Account

D.B. Root & Company, LLC Vertex Pharmaceuticals Inc Transaction History